Indications for intravenous iron therapy include inadequate therapeutic response to oral iron therapy, anemia requiring rapid normalization, or simultaneous use of erythropoiesis stimulating proteins (e.g., recombinant human erythropoietin [rhEPO], NESP) [40]. This evidence concerns the gene EPO and anemia.